Guinean President Alpha Conde announced a series of measures including strict controls at border points, travel restrictions and a ban on moving bodies "from one town to another until the end of the epidemic".
In addition all suspected victims will automatically be hospitalised until they are cleared of infection, Conde said.
As the region scrambled to halt the spread of the virus, Gambia suspended all flights from Guinea, Liberia and Sierra Leone, according to a transport ministry document obtained by AFP yesterday.
Canada's Health Minister Rona Ambrose said between 800 to 1,000 doses of a vaccine called VSV-EBOV, which has shown promise in animal research but never been tested on humans, would be distributed through the WHO.
Hard-hit nations were also anxiously awaiting a consignment of up to 1,000 doses of the barely-tested drug ZMapp from the US, which has raised hopes of saving hundreds infected with the disease.
Liberia is trying to save the lives of two infected doctors and is hoping that the ZMapp serum, which has shown positive early results, arrives in time.
Sierra Leone's health ministry spokesman Sidi Yahya Tunis told AFP the country had officially requested a shipment of the drug as the nation lost its second top doctor to the virus.
There is currently no available cure or vaccine for Ebola, which the WHO has declared a global public health emergency, and the use of experimental drugs has stoked a fierce debate.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
